Treatment Innovations

Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging rivannas-accuro-xv-secures-fda-clearance-a-new-frontier-in-point-of-care-musculoskeletal-imaging

rivannas-accuro-xv-secures-fda-clearance-a-new-frontier-in-point-of-care-musculoskeletal-imaging

Rivanna’s Accuro XV Secures FDA Clearance: A New Frontier in Point-of-Care Musculoskeletal Imaging

Ammar Sabilarrohman May 8, 2026

In a major milestone for point-of-care diagnostics, Virginia-based medical technology innovator Rivanna has received US Food and...

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay

Nila Kartika Wati September 9, 2025

By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...

From Spreadsheets to Strategy: How AI is Overhauling the $5.9 Million Clinical Data Bottleneck from-spreadsheets-to-strategy-how-ai-is-overhauling-the-5-9-million-clinical-data-bottleneck

from-spreadsheets-to-strategy-how-ai-is-overhauling-the-5-9-million-clinical-data-bottleneck

From Spreadsheets to Strategy: How AI is Overhauling the $5.9 Million Clinical Data Bottleneck

Pevita Pearce August 4, 2025

In the high-stakes world of pharmaceutical development, where a single Phase 3 clinical trial can represent billions...